产品名称 K562-Puro+TNFSF9/41BBL(h) 稳转株 产品货号 VGC-0001-025P 中文名称 TNFSF9/41BBL(h) 过表达 K562 稳转株 Lot number K562-34H8P 细胞规格 复苏细胞 (T25细胞瓶) 或1 × 106 细胞冻存细胞 细胞形态 淋巴母细胞样 生长特性 悬浮生长 细胞株 构建流程 (1)构建目的基因过表达慢病毒重组质粒...
41BBL胞膜外区蛋白对人外周血淋巴细胞体外活性的调节作用 目录 1材料和方法 1.1材料 1.2方法 50U/mL 2结果 2.1促进淋巴细胞增殖并改善存活状态 2.2促进淋巴细胞IL 2分泌 2.3联合应用anti CD3/anti Pgp、ex4 1BBL及PBL 杀伤K562/A02细胞采用CytoTox96试剂盒检测不同处理组的特异性杀伤 T为20∶1时分别为(51.94...
CytoTox 96检测其联合应用anti CD3/anti Pgp微型双功能抗体及PBL对靶细胞K562/A02细胞的杀伤作用。结果: 4 1BBL胞膜外区融合蛋白能够促进淋巴细胞增殖, 减少细胞死亡, 促进IL 2分泌; 联合应用ex4 1BBL的淋巴细胞组的杀伤效率优于对照组。结论: ex4 1BBL可能成为增强淋巴细胞活性的重要免疫佐剂。 【关键词】 4 ...
We proposed a phase II open, a prospective multicenter, non-randomized clinical trial for adoptive infusion of haploidentical K562-mb15-41BBL activated and expanded Natural Killer (NKAE) cells as a consolidation strategy in children with favorable and intermediate-risk AML who were in first ...
We proposed a phase 2, open, prospective, multicenter, nonrandomized clinical trial for the adoptive infusion of haploidentical K562-mb15-41BBL–activated and expanded NK (NKAE) cells as a consolidation strategy for children with favorable and intermediate risk AML in first complete remission after...
(brl3a,atcccrl1442);人类肺脏细胞(w138,atccccl75);人类肝脏细胞(hepg2,hb8065);小鼠乳腺肿瘤(mmt060562,atccccl51);tri细胞(matheretal.,annalsn.y.acad.sci.,383:44-681982);人类胎儿肺成纤维细胞(mrc5);fs4细胞;及人类肝肿瘤品系(hepg2)、per.c6、人类慢性骨髓性白血病细胞(k562),及中国仓鼠卵巢细胞...
(brl3a,atcccrl1442);人类肺脏细胞(w138,atccccl75);人类肝脏细胞(hepg2,hb8065);小鼠乳腺肿瘤(mmt060562,atccccl51);tri细胞(matheretal.,annalsn.y.acad.sci.,383:44-681982);人类胎儿肺成纤维细胞(mrc5);fs4细胞;及人类肝肿瘤品系(hepg2)、per.c6、人类慢性骨髓性白血病细胞(k562),及中国仓鼠卵巢细胞...
We proposed a phase 2, open, prospective, multicenter, nonrandomized clinical trial for the adoptive infusion of haploidentical K562-mb15-41BBLeactivated and expanded natural killer (NKAE) cells as a consolidation strategy for children with favorable and intermediate risk acute myeloid leukemia in ...